On Friday, Editas Medicine Inc (EDIT) stock saw a modest uptick, ending the day at $3.36 which represents a slight increase of $0.05 or 1.51% from the prior close of $3.31. The stock opened at $3.32 ...
Fintel reports that on October 18, 2024, Cantor Fitzgerald downgraded their outlook for Lilium N.V. (NasdaqGS:LILM) from ...
Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Closing Bell' to discuss the bullish case for ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 60.77% ...
CME Group Inc. is amping up the battle for market share in US Treasury futures, pulling all stops to thwart Howard Lutnick’s ...
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
PagSeguro Digital (NYSE:PAGS – Get Free Report) had its price objective lowered by research analysts at Barclays from $16.00 ...
In Arizona, older people recently received a mailer declaring Medicare had been cancelled. It had a big red stamp that ...
Vice President Kamala Harris and former President Donald Trump are running markedly different transition efforts to be ready ...
Two supercharged income stocks -- sporting yields of 5.6% and 5.8% -- have the tools and intangibles needed to catapult ...
Cantor Fitzgerald reiterated their neutral rating on shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Free Report) in a ...